ID ENTE_ECOLI Reviewed; 536 AA. AC P10378; P15049; P77773; Q2MBK7; DT 01-JUL-1989, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1997, sequence version 3. DT 02-SEP-2026, entry version 195. DE RecName: Full=Enterobactin synthase component E {ECO:0000303|PubMed:9485415}; DE EC=6.3.2.14 {ECO:0000269|PubMed:10688898, ECO:0000269|PubMed:16567620, ECO:0000269|PubMed:19852513, ECO:0000269|PubMed:20359185, ECO:0000269|PubMed:20845982, ECO:0000269|PubMed:2531000, ECO:0000269|PubMed:9214294}; DE AltName: Full=2,3-dihydroxybenzoate-AMP ligase {ECO:0000303|PubMed:2531000}; DE Short=DHB-AMP ligase {ECO:0000303|PubMed:2531000}; DE AltName: Full=2,3-dihydroxybenzoate-AMP synthase {ECO:0000305}; DE EC=6.2.1.71 {ECO:0000269|PubMed:10688898, ECO:0000269|PubMed:16567620, ECO:0000269|PubMed:19852513, ECO:0000269|PubMed:20359185, ECO:0000269|PubMed:20845982, ECO:0000269|PubMed:2531000}; DE AltName: Full=Dihydroxybenzoic acid-activating enzyme {ECO:0000303|PubMed:2531000}; DE AltName: Full=Enterochelin synthase E {ECO:0000303|PubMed:9485415}; GN Name=entE {ECO:0000303|PubMed:2525505}; GN OrderedLocusNames=b0594, JW0586; OS Escherichia coli (strain K12). OC Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; OC Enterobacterales; Enterobacteriaceae; Escherichia. OX NCBI_TaxID=83333; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=K12; RX PubMed=2525505; DOI=10.1016/0378-1097(89)90450-3; RA Staab J.F., Elkins M.F., Earhart C.F.; RT "Nucleotide sequence of the Escherichia coli entE gene."; RL FEMS Microbiol. Lett. 50:15-19(1989). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / MG1655 / ATCC 47076; RA Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M., RA Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D., RA Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.; RT "Sequence of minutes 4-25 of Escherichia coli."; RL Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / MG1655 / ATCC 47076; RX PubMed=9278503; DOI=10.1126/science.277.5331.1453; RA Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V., RA Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F., RA Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B., RA Shao Y.; RT "The complete genome sequence of Escherichia coli K-12."; RL Science 277:1453-1462(1997). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911; RX PubMed=16738553; DOI=10.1038/msb4100049; RA Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S., RA Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.; RT "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 RT and W3110."; RL Mol. Syst. Biol. 2:E1-E5(2006). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-8. RC STRAIN=K12; RX PubMed=2110093; DOI=10.1111/j.1574-6968.1990.tb04118.x; RA Elkins M.F., Earhart C.F.; RT "Opacity factor from group A streptococci is an apoproteinase."; RL FEMS Microbiol. Lett. 56:35-39(1990). RN [6] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 393-536. RX PubMed=2521622; DOI=10.1128/jb.171.2.791-798.1989; RA Liu J., Duncan K., Walsh C.T.; RT "Nucleotide sequence of a cluster of Escherichia coli enterobactin RT biosynthesis genes: identification of entA and purification of its product RT 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase."; RL J. Bacteriol. 171:791-798(1989). RN [7] RP INDUCTION. RX PubMed=6227609; DOI=10.1128/jb.156.3.1171-1177.1983; RA Fleming T.P., Nahlik M.S., McIntosh M.A.; RT "Regulation of enterobactin iron transport in Escherichia coli: RT characterization of ent::Mu d(Apr lac) operon fusions."; RL J. Bacteriol. 156:1171-1177(1983). RN [8] RP FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND RP SUBSTRATE SPECIFICITY. RX PubMed=2531000; DOI=10.1021/bi00443a008; RA Rusnak F., Faraci W.S., Walsh C.T.; RT "Subcloning, expression, and purification of the enterobactin biosynthetic RT enzyme 2,3-dihydroxybenzoate-AMP ligase: demonstration of enzyme-bound RT (2,3-dihydroxybenzoyl)adenylate product."; RL Biochemistry 28:6827-6835(1989). RN [9] RP INDUCTION. RX PubMed=2521621; DOI=10.1128/jb.171.2.784-790.1989; RA Nahlik M.S., Brickman T.J., Ozenberger B.A., McIntosh M.A.; RT "Nucleotide sequence and transcriptional organization of the Escherichia RT coli enterobactin biosynthesis cistrons entB and entA."; RL J. Bacteriol. 171:784-790(1989). RN [10] RP FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBSTRATE RP SPECIFICITY. RX PubMed=9214294; DOI=10.1021/bi970453p; RA Gehring A.M., Bradley K.A., Walsh C.T.; RT "Enterobactin biosynthesis in Escherichia coli: isochorismate lyase (EntB) RT is a bifunctional enzyme that is phosphopantetheinylated by EntD and then RT acylated by EntE using ATP and 2,3-dihydroxybenzoate."; RL Biochemistry 36:8495-8503(1997). RN [11] RP FUNCTION, AND SUBUNIT. RX PubMed=9485415; DOI=10.1021/bi9726584; RA Gehring A.M., Mori I., Walsh C.T.; RT "Reconstitution and characterization of the Escherichia coli enterobactin RT synthetase from EntB, EntE, and EntF."; RL Biochemistry 37:2648-2659(1998). RN [12] RP SUBCELLULAR LOCATION. RX PubMed=10692387; DOI=10.1128/jb.182.6.1768-1773.2000; RA Hantash F.M., Earhart C.F.; RT "Membrane association of the Escherichia coli enterobactin synthase RT proteins EntB/G, EntE, and EntF."; RL J. Bacteriol. 182:1768-1773(2000). RN [13] RP FUNCTION, CATALYTIC ACTIVITY, AND REACTION MECHANISM. RX PubMed=10688898; DOI=10.1073/pnas.040572897; RA Ehmann D.E., Shaw-Reid C.A., Losey H.C., Walsh C.T.; RT "The EntF and EntE adenylation domains of Escherichia coli enterobactin RT synthetase: sequestration and selectivity in acyl-AMP transfers to RT thiolation domain cosubstrates."; RL Proc. Natl. Acad. Sci. U.S.A. 97:2509-2514(2000). RN [14] RP FUNCTION, MUTAGENESIS OF ARG-437; LYS-473 AND ARG-494, BIOPHYSICOCHEMICAL RP PROPERTIES, AND REACTION MECHANISM. RX PubMed=16632253; DOI=10.1016/j.chembiol.2006.02.005; RA Drake E.J., Nicolai D.A., Gulick A.M.; RT "Structure of the EntB multidomain nonribosomal peptide synthetase and RT functional analysis of its interaction with the EntE adenylation domain."; RL Chem. Biol. 13:409-419(2006). RN [15] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=16567620; DOI=10.1073/pnas.0601038103; RA Lai J.R., Fischbach M.A., Liu D.R., Walsh C.T.; RT "A protein interaction surface in nonribosomal peptide synthesis mapped by RT combinatorial mutagenesis and selection."; RL Proc. Natl. Acad. Sci. U.S.A. 103:5314-5319(2006). RN [16] RP FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND RP MISCELLANEOUS. RX PubMed=19852513; DOI=10.1021/bi901680m; RA Sikora A.L., Cahill S.M., Blanchard J.S.; RT "Enterobactin synthetase-catalyzed formation of P(1),P(3)-diadenosine-5'- RT tetraphosphate."; RL Biochemistry 48:10827-10829(2009). RN [17] RP FUNCTION, AND SUBSTRATE SPECIFICITY. RX PubMed=19699210; DOI=10.1016/j.jmb.2009.08.036; RA Khalil S., Pawelek P.D.; RT "Ligand-induced conformational rearrangements promote interaction between RT the Escherichia coli enterobactin biosynthetic proteins EntE and EntB."; RL J. Mol. Biol. 393:658-671(2009). RN [18] RP FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY RP REGULATION, AND REACTION MECHANISM. RX PubMed=20359185; DOI=10.1021/bi100350c; RA Sikora A.L., Wilson D.J., Aldrich C.C., Blanchard J.S.; RT "Kinetic and inhibition studies of dihydroxybenzoate-AMP ligase from RT Escherichia coli."; RL Biochemistry 49:3648-3657(2010). RN [19] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=20845982; DOI=10.1021/bi1012854; RA Felnagle E.A., Barkei J.J., Park H., Podevels A.M., McMahon M.D., RA Drott D.W., Thomas M.G.; RT "MbtH-like proteins as integral components of bacterial nonribosomal RT peptide synthetases."; RL Biochemistry 49:8815-8817(2010). RN [20] RP FUNCTION, SUBUNIT, AND ACTIVITY REGULATION. RX PubMed=21166461; DOI=10.1021/bi101558v; RA Khalil S., Pawelek P.D.; RT "Enzymatic adenylation of 2,3-dihydroxybenzoate is enhanced by a protein- RT protein interaction between Escherichia coli 2,3-dihydro-2,3- RT dihydroxybenzoate dehydrogenase (EntA) and 2,3-dihydroxybenzoate-AMP ligase RT (EntE)."; RL Biochemistry 50:533-545(2011). RN [21] RP X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) IN COMPLEX WITH SUBSTRATE ANALOG AND RP PHOSPHOPANTETHEINE, AND SUBUNIT. RX PubMed=22365602; DOI=10.1016/j.chembiol.2011.11.013; RA Sundlov J.A., Shi C., Wilson D.J., Aldrich C.C., Gulick A.M.; RT "Structural and functional investigation of the intermolecular interaction RT between NRPS adenylation and carrier protein domains."; RL Chem. Biol. 19:188-198(2012). RN [22] RP X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF CHIMERIC ENTE-ENTB CONSTRUCT IN RP COMPLEX WITH SUBSTRATE ANALOG AND PHOSPHOPANTETHEINE, AND SUBUNIT. RX PubMed=23897471; DOI=10.1107/s0907444913009372; RA Sundlov J.A., Gulick A.M.; RT "Structure determination of the functional domain interaction of a chimeric RT nonribosomal peptide synthetase from a challenging crystal with RT noncrystallographic translational symmetry."; RL Acta Crystallogr. D 69:1482-1492(2013). CC -!- FUNCTION: Involved in the biosynthesis of the siderophore enterobactin CC (enterochelin), which is a macrocyclic trimeric lactone of N-(2,3- CC dihydroxybenzoyl)-serine. The serine trilactone serves as a scaffolding CC for the three catechol functionalities that provide hexadentate CC coordination for the tightly ligated iron(2+) atoms. EntE processes via CC a two-step adenylation-ligation reaction (bi-uni-uni-bi ping-pong CC mechanism). First, it catalyzes the activation of the carboxylate group CC of 2,3-dihydroxy-benzoate (DHB), via a reversible ATP-dependent CC pyrophosphate exchange reactions to yield the acyladenylate CC intermediate 2,3-dihydroxybenzoyl-AMP. It can also transfer AMP to CC salicylate, 2,4-dihydroxybenzoate, gentisate and 2,3,4- CC trihydroxybenzoate. In the second step, DHB is transferred from 2,3- CC dihydroxybenzoyl-AMP onto the phosphopantetheinylated EntB (holo-EntB) CC to form DHB-holo-EntB. Then this product will serve in the formation of CC the amide bond between 2,3-dihydroxybenzoate (DHB) and L-serine. It can CC also transfer adenylated salicylate to holo-EntB. CC {ECO:0000269|PubMed:10688898, ECO:0000269|PubMed:16567620, CC ECO:0000269|PubMed:16632253, ECO:0000269|PubMed:19699210, CC ECO:0000269|PubMed:19852513, ECO:0000269|PubMed:20359185, CC ECO:0000269|PubMed:20845982, ECO:0000269|PubMed:21166461, CC ECO:0000269|PubMed:2531000, ECO:0000269|PubMed:9214294}. CC -!- CATALYTIC ACTIVITY: CC Reaction=3 2,3-dihydroxybenzoate + 3 L-serine + 6 ATP = enterobactin + CC 6 AMP + 6 diphosphate + 4 H(+); Xref=Rhea:RHEA:30571, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:33384, ChEBI:CHEBI:36654, ChEBI:CHEBI:77805, CC ChEBI:CHEBI:456215; EC=6.3.2.14; CC Evidence={ECO:0000269|PubMed:10688898, ECO:0000269|PubMed:16567620, CC ECO:0000269|PubMed:19852513, ECO:0000269|PubMed:20359185, CC ECO:0000269|PubMed:20845982, ECO:0000269|PubMed:2531000, CC ECO:0000269|PubMed:9214294}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2,3-dihydroxybenzoate + holo-[ACP] + ATP = 2,3- CC dihydroxybenzoyl-[ACP] + AMP + diphosphate; Xref=Rhea:RHEA:61652, CC Rhea:RHEA-COMP:9685, Rhea:RHEA-COMP:19024, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:36654, ChEBI:CHEBI:64479, CC ChEBI:CHEBI:90610, ChEBI:CHEBI:456215; EC=6.2.1.71; CC Evidence={ECO:0000269|PubMed:10688898, ECO:0000269|PubMed:16567620, CC ECO:0000269|PubMed:19852513, ECO:0000269|PubMed:20359185, CC ECO:0000269|PubMed:20845982, ECO:0000269|PubMed:2531000}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2,3-dihydroxybenzoyl-5'-AMP + holo-[ACP] = 2,3- CC dihydroxybenzoyl-[ACP] + AMP + H(+); Xref=Rhea:RHEA:48604, Rhea:RHEA- CC COMP:9685, Rhea:RHEA-COMP:19024, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57417, ChEBI:CHEBI:64479, ChEBI:CHEBI:90610, CC ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:10688898, CC ECO:0000269|PubMed:16567620, ECO:0000269|PubMed:19852513, CC ECO:0000269|PubMed:20359185, ECO:0000269|PubMed:20845982, CC ECO:0000269|PubMed:9214294, ECO:0000269|PubMed:9485415}; CC -!- ACTIVITY REGULATION: Inhibited by the adenylate analogs, 5'-O-[N- CC (salicyl)sulfamoyl]adenosine (Sal-AMS) and 5'-O-[N-(2,3- CC dihydroxybenzoyl)sulfamoyl]adenosine (DHB-AMS). Adenylation of 2,3- CC dihydroxybenzoate (DHB) is enhanced by a protein-protein interaction CC between the EntA and EntE. {ECO:0000269|PubMed:20359185, CC ECO:0000269|PubMed:21166461}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=0.4 uM for holo-EntB (at pH 8.8 and 37 degrees Celsius) CC {ECO:0000269|PubMed:9214294}; CC KM=0.5 uM for holo-EntB {ECO:0000269|PubMed:16567620}; CC KM=2.5 uM for DHB (at pH 7.8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:20359185}; CC KM=2.7 uM for DHB {ECO:0000269|PubMed:2531000}; CC KM=2.9 uM for DHB {ECO:0000269|PubMed:20845982}; CC KM=2.9 uM for holo-EntB (at pH 7.8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:20359185}; CC KM=23.3 uM for holo-EntB (at pH 7.5 and 37 degrees Celsius) CC {ECO:0000269|PubMed:16632253}; CC KM=70 uM for 3-hydroxybenzoate (at pH 7.8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:20359185}; CC KM=70 uM for salicylate (at pH 7.8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:20359185}; CC KM=400 uM for 5,5-diadenosine tetraphosphate CC {ECO:0000269|PubMed:19852513}; CC KM=430 uM for ATP (at pH 7.8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:20359185}; CC KM=1200 uM for ATP {ECO:0000269|PubMed:2531000}; CC KM=3100 uM for 4-aminosalicylate (at pH 7.8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:20359185}; CC KM=34.2 mM for D-pantetheine (at pH 7.8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:20359185}; CC Vmax=3168.2 pmol/min/mg enzyme {ECO:0000269|PubMed:20845982}; CC Note=kcat is 0.3 sec(-1) for 2,3-dihydroxybenzoate-AMP ligase CC activity with 3-hydroxybenzoate as substrate (at pH 7.8 and 25 CC degrees Celsius). kcat is 0.8 sec(-1) for 2,3-dihydroxybenzoate-AMP CC ligase activity with salicylate as substrate (at pH 7.8 and 25 CC degrees Celsius). kcat is 0.9 sec(-1) for CC S-dihydroxybenzoyltransferase activity with D-pantetheine as CC substrate (at pH 7.8 and 25 degrees Celsius). kcat is 2.8 sec(-1) for CC 2,3-dihydroxybenzoate-AMP ligase activity with ATP and DHB as CC substrates (at pH 7.8 and 25 degrees Celsius). kcat is 2.8 sec(-1) CC for S-dihydroxybenzoyltransferase activity with holo-EntB as CC substrate (at pH 7.8 and 25 degrees Celsius). kcat is 4.4 sec(-1) for CC 2,3-dihydroxybenzoate-AMP ligase activity with 4-aminosalicylate as CC substrate (at pH 7.8 and 25 degrees Celsius). kcat is 5.94 sec(-1) CC for S-dihydroxybenzoyltransferase activity with holo-EntB as CC substrate (at pH 7.8 and 25 degrees Celsius). kcat is 100 min(-1) for CC S-dihydroxybenzoyltransferase activity with holo-EntB as substrate CC (at pH 8.8 and 37 degrees Celsius). kcat is 140 min(-1) for CC S-dihydroxybenzoyltransferase activity with holo-EntB as substrate. CC {ECO:0000269|PubMed:16567620, ECO:0000269|PubMed:16632253, CC ECO:0000269|PubMed:20359185, ECO:0000269|PubMed:9214294}; CC -!- PATHWAY: Siderophore biosynthesis; enterobactin biosynthesis. CC {ECO:0000305|PubMed:9485415}. CC -!- SUBUNIT: Proteins EntB, EntD, EntE, and EntF form a multienzyme complex CC called enterobactin synthase. Monomer. EntA and EntE interact together. CC {ECO:0000269|PubMed:21166461, ECO:0000269|PubMed:22365602, CC ECO:0000269|PubMed:23897471, ECO:0000269|PubMed:2531000, CC ECO:0000269|PubMed:9485415}. CC -!- INTERACTION: CC P10378; P15047: entA; NbExp=5; IntAct=EBI-550322, EBI-1118936; CC P10378; P0ADI4: entB; NbExp=3; IntAct=EBI-550322, EBI-547993; CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10692387}. CC -!- INDUCTION: Under conditions of iron deficiency and by the fur protein. CC {ECO:0000269|PubMed:2521621, ECO:0000269|PubMed:6227609}. CC -!- MISCELLANEOUS: In the absence of holo-EntB, EntE can transfer the CC adenylate moiety of the 2,3-dihydroxybenzoyl-AMP intermediate to ATP, CC generating the stress signaling molecule Ap4A involved in the CC regulation of cell division during oxidative stress, and releasing 2,3- CC dihydroxybenzoate. It seems that the expression of EntE during iron CC starvation produces Ap(4)A to slow growth until intracellular iron CC stores can be restored. {ECO:0000269|PubMed:19852513}. CC -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family. CC EntE subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X15058; CAA33158.1; -; Genomic_DNA. DR EMBL; U82598; AAB40794.1; -; Genomic_DNA. DR EMBL; U00096; AAC73695.1; -; Genomic_DNA. DR EMBL; AP009048; BAE76349.1; -; Genomic_DNA. DR EMBL; M24148; AAA16101.1; -; Unassigned_DNA. DR EMBL; M36700; AAA18492.1; -; Genomic_DNA. DR PIR; H64792; SYECEB. DR RefSeq; NP_415126.1; NC_000913.3. DR RefSeq; WP_000026812.1; NZ_CP009789.1. DR PDB; 3RG2; X-ray; 3.10 A; A/B/C/D/E/F/G/H/I/J=1-536. DR PDB; 4IZ6; X-ray; 2.40 A; A/B=1-536. DR PDB; 6IYK; X-ray; 2.45 A; A/B=1-536. DR PDB; 6IYL; X-ray; 2.56 A; A/B=1-536. DR PDB; 8K5S; X-ray; 2.65 A; A/B=1-536. DR PDB; 8K5T; X-ray; 2.80 A; A/B=1-536. DR AlphaFoldDB; P10378; -. DR SMR; P10378; -. DR BioGRID; 4259905; 326. DR BioGRID; 851747; 5. DR ComplexPortal; CPX-5747; entAE 2,3-dihydroxybenzoate-AMP ligase complex. DR ComplexPortal; CPX-5748; entBE aryl carrier complex. DR DIP; DIP-9515N; -. DR FunCoup; P10378; 50. DR IntAct; P10378; 14. DR STRING; 511145.b0594; -. DR BindingDB; P10378; -. DR ChEMBL; CHEMBL4856; -. DR jPOST; P10378; -. DR PaxDb; 511145-b0594; -. DR EnsemblBacteria; AAC73695; AAC73695; b0594. DR GeneID; 947426; -. DR KEGG; ecj:JW0586; -. DR KEGG; eco:b0594; -. DR KEGG; ecoc:C3026_02965; -. DR PATRIC; fig|1411691.4.peg.1675; -. DR EchoBASE; EB0259; -. DR eggNOG; COG1021; Bacteria. DR HOGENOM; CLU_000022_59_7_6; -. DR InParanoid; P10378; -. DR OMA; TFRGYYR; -. DR OrthoDB; 9803968at2; -. DR PhylomeDB; P10378; -. DR BioCyc; EcoCyc:ENTE-MONOMER; -. DR BioCyc; MetaCyc:ENTE-MONOMER; -. DR BRENDA; 6.2.1.71; 2026. DR BRENDA; 6.3.2.14; 2026. DR UniPathway; UPA00017; -. DR PRO; PR:P10378; -. DR Proteomes; UP000000625; Chromosome. DR AbasyAtlas; P10378; -. DR GO; GO:0005829; C:cytosol; IDA:EcoCyc. DR GO; GO:0016020; C:membrane; EXP:UniProtKB. DR GO; GO:0008668; F:2,3-dihydroxybenzoate--[aryl-carrier protein] ligase activity; IDA:EcoCyc. DR GO; GO:0047527; F:2,3-dihydroxybenzoate-serine ligase activity; IDA:UniProtKB. DR GO; GO:0009239; P:enterobactin biosynthetic process; IDA:ComplexPortal. DR CDD; cd05920; 23DHB-AMP_lg; 1. DR FunFam; 3.30.300.30:FF:000021; Enterobactin synthase component E; 1. DR FunFam; 3.40.50.12780:FF:000031; Enterobactin synthase component E; 1. DR FunFam; 2.30.38.10:FF:000003; Vibriobactin-specific 2,3-dihydroxybenzoate-AMP ligase; 1. DR Gene3D; 3.30.300.30; -; 1. DR Gene3D; 3.40.50.12780; N-terminal domain of ligase-like; 1. DR InterPro; IPR045851; AMP-b_sf. DR InterPro; IPR025110; AMP-bd_C. DR InterPro; IPR020845; AMP-binding_CS. DR InterPro; IPR000873; AMP-dep_synth/lig_dom. DR InterPro; IPR042099; ANL_N_sf. DR InterPro; IPR050237; ATP-dep_AMP-bd_enzyme. DR InterPro; IPR011963; DHB_AMP_lig. DR NCBIfam; TIGR02275; DHB_AMP_lig; 1. DR NCBIfam; NF008192; PRK10946.1; 1. DR PANTHER; PTHR43767; LONG-CHAIN-FATTY-ACID--COA LIGASE; 1. DR PANTHER; PTHR43767:SF1; NONRIBOSOMAL PEPTIDE SYNTHASE PES1 (EUROFUNG)-RELATED; 1. DR Pfam; PF00501; AMP-binding; 1. DR Pfam; PF13193; AMP-binding_C; 1. DR SUPFAM; SSF56801; Acetyl-CoA synthetase-like; 1. DR PROSITE; PS00455; AMP_BINDING; 1. DR PDBsum; 3RG2; -. DR PDBsum; 4IZ6; -. DR PDBsum; 6IYK; -. DR PDBsum; 6IYL; -. DR PDBsum; 8K5S; -. DR PDBsum; 8K5T; -. PE 1: Evidence at protein level; KW 3D-structure; Acyltransferase; ATP-binding; Enterobactin biosynthesis; KW Ligase; Membrane; Nucleotide-binding; Reference proteome; Transferase. FT CHAIN 1..536 FT /note="Enterobactin synthase component E" FT /id="PRO_0000193075" FT REGION 438..439 FT /note="Phosphopantetheine binding" FT /evidence="ECO:0000269|PubMed:22365602, FT ECO:0000269|PubMed:23897471" FT BINDING 235 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:22365602" FT BINDING 240 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:23897471" FT BINDING 309 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:22365602, FT ECO:0000269|PubMed:23897471" FT BINDING 331 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:22365602, FT ECO:0000269|PubMed:23897471" FT BINDING 335 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:22365602" FT BINDING 415 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:22365602, FT ECO:0000269|PubMed:23897471" FT BINDING 432 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:23897471" FT BINDING 441 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:23897471" FT MUTAGEN 437 FT /note="R->D: Catalyzes the adenylation reaction with 10% FT reduction of activity compared to the wild-type. 3% FT reduction of activity compared to the wild-type; when FT associated with D-473." FT /evidence="ECO:0000269|PubMed:16632253" FT MUTAGEN 473 FT /note="K->D: Catalyzes the adenylation reaction with same FT activity as the wild-type. 3% reduction of activity FT compared to the wild-type; when associated with D-437." FT /evidence="ECO:0000269|PubMed:16632253" FT MUTAGEN 494 FT /note="R->D: Catalyzes the adenylation reaction with same FT activity as the wild-type." FT /evidence="ECO:0000269|PubMed:16632253" FT CONFLICT 369..378 FT /note="DAEGNPLPQG -> ECRRKSTAAR (in Ref. 1; CAA33158)" FT /evidence="ECO:0000305" FT HELIX 7..9 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 10..18 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 29..32 FT /evidence="ECO:0007829|PDB:4IZ6" FT TURN 33..36 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 39..44 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 47..50 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 51..67 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 75..79 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 84..96 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 99..103 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 109..119 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 122..127 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 131..133 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 134..136 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 137..145 FT /evidence="ECO:0007829|PDB:4IZ6" FT TURN 146..148 FT /evidence="ECO:0007829|PDB:8K5T" FT STRAND 151..155 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 163..168 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 178..180 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 183..189 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 193..196 FT /evidence="ECO:0007829|PDB:6IYK" FT STRAND 199..203 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 204..218 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 225..228 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 235..239 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 242..249 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 252..255 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 261..271 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 275..278 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 280..291 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 296..299 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 304..310 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 311..313 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 314..323 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 326..334 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 337..341 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 348..353 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 357..360 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 364..368 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 370..372 FT /evidence="ECO:0007829|PDB:8K5T" FT STRAND 380..386 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 388..390 FT /evidence="ECO:0007829|PDB:8K5T" FT HELIX 398..404 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 411..419 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 425..430 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 432..437 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 440..443 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 444..451 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 457..467 FT /evidence="ECO:0007829|PDB:4IZ6" FT TURN 468..470 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 471..482 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 486..494 FT /evidence="ECO:0007829|PDB:4IZ6" FT TURN 495..497 FT /evidence="ECO:0007829|PDB:3RG2" FT HELIX 500..502 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 505..509 FT /evidence="ECO:0007829|PDB:4IZ6" FT STRAND 519..521 FT /evidence="ECO:0007829|PDB:4IZ6" FT HELIX 523..531 FT /evidence="ECO:0007829|PDB:4IZ6" SQ SEQUENCE 536 AA; 59112 MW; F818942DFDD8DC99 CRC64; MSIPFTRWPE EFARRYREKG YWQDLPLTDI LTRHAASDSI AVIDGERQLS YRELNQAADN LACSLRRQGI KPGETALVQL GNVAELYITF FALLKLGVAP VLALFSHQRS ELNAYASQIE PALLIADRQH ALFSGDDFLN TFVTEHSSIR VVQLLNDSGE HNLQDAINHP AEDFTATPSP ADEVAYFQLS GGTTGTPKLI PRTHNDYYYS VRRSVEICQF TQQTRYLCAI PAAHNYAMSS PGSLGVFLAG GTVVLAADPS ATLCFPLIEK HQVNVTALVP PAVSLWLQAL IEGESRAQLA SLKLLQVGGA RLSATLAARI PAEIGCQLQQ VFGMAEGLVN YTRLDDSAEK IIHTQGYPMC PDDEVWVADA EGNPLPQGEV GRLMTRGPYT FRGYYKSPQH NASAFDANGF YCSGDLISID PEGYITVQGR EKDQINRGGE KIAAEEIENL LLRHPAVIYA ALVSMEDELM GEKSCAYLVV KEPLRAVQVR RFLREQGIAE FKLPDRVECV DSLPLTAVGK VDKKQLRQWL ASRASA //